New Trends in Dyslipidemia Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Trends in Dyslipidemia Treatment

Published:2021-05-25 Issue:6 Volume:85 Page:759-768
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Jang Albert Youngwoo¹,Lim Soo²,Jo Sang-Ho³,Han Seung Hwan¹,Koh Kwang Kon¹

Affiliation:

1. Division of Cardiovascular Disease, Gachon University Gil Hospital and Gachon Cardiovascular Research Institute

2. Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital

3. Cardiovascular Center, Hallym University Sacred Heart Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/85/6/85_CJ-20-1037/_pdf

Reference73 articles.

1. 1. Cholesterol Treatment Trialists (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670–1681.

2. 2. Marston NA, Giugliano RP, Im K, Silverman MG, O’Donoghue ML, Wiviott SD, et al. Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: A systematic review and meta-regression analysis of randomized controlled trials. Circulation 2019; 140: 1308–1317.

3. 3. Orkaby AR, Driver JA, Ho YL, Lu B, Costa L, Honerlaw J, et al. Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA 2020; 324: 68–78.

4. 4. Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, et al. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA 2019; 321: 364–373.

5. 5. Lim S, Park YM, Sakuma I, Koh KK. How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol. Int J Cardiol 2013; 166: 8–14.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

2. Efficacy and Safety of Bempedoic Acid in Patients with High Cardiovascular Risk: An Update;Current Vascular Pharmacology;2024-07

3. Triglyceride-rich lipoproteins and cardiovascular diseases;Frontiers in Endocrinology;2024-05-31

4. Curcumin Equipped Nanozyme‐Like Metal−Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability;Advanced Science;2024-05-02

5. МЕТАБОЛІЧНИЙ СИНДРОМ: ПОГЛЯД НА ПРОБЛЕМУ;Здобутки клінічної і експериментальної медицини;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3